teneima
10-12-2022, 05:38 AM
On the basis of the seven recent, more methodologically robust studies 4 10 highlighted in this review Table 3, there is not clear and consistent evidence of a protective effect of rrBSO on breast cancer risk for either BRCA1 or BRCA2 mutation carriers metolazone and lasix ([Only registered and activated users can see links])